OpGen (OPGN)
(Delayed Data from OTC)
$1.77 USD
-0.18 (-9.23%)
Updated Aug 27, 2024 03:07 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPGN 1.77 -0.18(-9.23%)
Will OPGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPGN
GoodRx Holdings, Inc. (GDRX) Misses Q1 Earnings Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
OPGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bright Health Group (BHG) Reports Q2 Loss, Lags Revenue Estimates
Buy 5 Top-Ranked Stocks With Rising P/E in July
Bet on DuPont Analysis to Pick 5 Stocks for Stellar Returns
Other News for OPGN
OPGN Stock Earnings: OpGen Reported Results for Q2 2024
OpGen Bolsters Board with Five New Industry Experts
OpGen Leadership Changes: CEO Resigns, New Chairman Appointed
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
OPGN Stock Earnings: OpGen Meets Revenue for Q4 2023